CooperVision
CooperVision, a division of CooperCompanies (Nasdaq: COO), is one of the world’s leading manufacturers of contact lenses. The company produces a full array of daily disposable, two-week and monthly soft contact lenses that feature advanced materials and optics, and premium rigid gas permeable lenses for orthokeratology and scleral designs.
Through advanced solutions such as daily disposable soft contact lenses, orthokeratology lenses, and spectacle lenses, they are committed to combating myopia progression in children. By leveraging cutting-edge technology and evidence-based approaches, CooperVision is revolutionizing the way we approach myopia, empowering patients, parents, and eye care professionals to proactively preserve long-term vision health for future generations.
CooperVision sponsored articles.
CooperVision myopia management products
Myopia management products listed by Myopia Profile have been specifically designed for myopia control or myopia management in children, and have some form of regulatory approval or marking for this form of use. They also have randomized controlled trial research data supporting their efficacy, unless otherwise noted. It is up to the individual eye care practitioner to be aware of regulatory requirements for prescribing in their country of practice, and also be aware that not all products are available in all countries.
MiSight® 1 day
The first FDA-approved treatment to slow the progression of myopia in children as young as 8 years old.*1 Original MiSight® 1 day contact lenses are the #1 most fitted soft contact lenses for myopia control in children†2 and backed by a 7-year clinical trial – the longest-running soft contact lens study among children.
*Compared to a single vision 1 day lens over a 3-year period.
† Based on available fit data in the UK and US for patients under 20
1. Chamberlain P, et al. A 3-year Randomized Clinical Trial of MiSight Lenses for Myopia Control. OVS 2019;96:556-567.
2. CVI Data on file 2025, MiSight 1 day and similar lens types - patients under 20.
MyDay® MiSight® 1 day
Features MiSight® 1 day ActivControl® Technology combined with the advanced silicone hydrogel material used in MyDay® lenses.*1
Now your patients can enjoy the same clear vision2 and myopia control benefits of the original MiSight®1 day,3 with the all-day comfort2 and breathability2 that millions of MyDay® wearers experience worldwide.4
*Proven to slow myopia progression in children compared to a single vision 1-day lens over a 3-year period.
1. Chamberlain P, et al. A 3-year Randomized Clinical Trial of MiSight Lenses for Myopia Control. OVS 2019;96:556-567.
2. CVI data on file, 2025.
3. CVI data on file 2025. Prospective, 1-week, double masked, randomized, bilateral crossover study with MiSight 1 day and MyDay MiSight 1 day. N=32 subjects aged 8-18 years.
4. CVI data on file, 2020.
DreamLite® MC
DreamLite® MC orthokeratology lenses by CooperVision are worn overnight, and removed each morning.* They offer eye care practitioners a robust myopia management solution and have European approval for slowing myopia progression in children and young adults. They are well suited for children with myopia who are extremely active, especially those who play high-impact sports or water sports.1 DreamLite® MC contact lenses control myopia while allowing wearers to enjoy clear vision with freedom from spectacles or daytime contact lenses.*
The lenses are currently available in Europe and China.
*Swarbrick HA. Orthokeratology (corneal refractive therapy): what is it and how does it work? Eye Contact Lens. 2004 Oct;30(4):181-5; discussion 205-6.
Paragon CRT®
Paragon CRT® contact lenses are orthokeratology contact lenses that have been used by eye care professionals for myopia management for two decades, following the first FDA approval for overnight wear contact lenses indicated for the temporary reduction of myopia. They also slow axial elongation when worn every night.*1 Paragon CRT® orthokeratology lenses can be fit empirically, with a diagnostic set, or using an online calculator at CRTcalculator.com.
* Over a 2-year study period.
1. VanderVeen, Deborah K., et al. Use of orthokeratology for the prevention of myopic progression in children: a report by the American Academy of Ophthalmology. Ophthalmology 126.4 (2019): 623-636.
CooperVision resources
Myopia Simulator
CooperVision has made a myopia simulator to help patients, parents and practitioners understand the experience of myopia. Launch it to find out more - you can use it in your daily practice to help explain myopia to parents and patients.
One Thing - my myopia management journey
As part of Myopia Action Month 2023, CooperVision asked myopia experts around the world "What's the one thing that motivated you to start with myopia management?" Listen to leaders in the field discuss their journey into myopia management, and what they have learnt along the way.
The MiSight® 1 day Story
MiSight® 1 day contact lenses hold the largest body of evidence for childhood myopia management with soft contact lenses - listen to experts and researchers discuss the science behind MiSight® 1 day , and how this extensive and compelling research translates into practice.